Ashutosh Jogalekar

Ashutosh Jogalekar is a highly experienced scientist with over ten years of experience in modeling, simulation, and early-stage drug discovery. He has particular expertise in structure-based design, HTS data analysis, and library design of small molecules. Ashutosh is currently working at Revolution Medicines, where he is designing leads for high-value cancer targets and adopting promising experimental and computational technologies. He has previously worked at Warp Drive Bio and Ensemble Therapeutics, where he worked on frontier drug targets and created and validated high-value chemical matter for unmet therapeutic needs.

Aside from his professional experience, Ashutosh is also an accomplished science writer and historian, having written for Scientific American and been an official journalist at the Lindau Meeting of Nobel Laureates. His interests include the history and philosophy of science and technology.